Comparison
11q Partial Monosomy Syndrome C0795841 vs 17 20 Lyase Deficiency Isolated Included CN372394
Clinical comparison between 11q Partial Monosomy Syndrome and 17 20 Lyase Deficiency Isolated Included CN372394 for differential diagnosis and treatment planning.
11q Partial Monosomy Syndrome C0795841
A chromosomal disorder from missing genetic material on chromosome 11. It typically causes developmental delays, intellectual disability, and facial differences. Care focuses on symptom management and developmental interventions.
17 20 Lyase Deficiency Isolated Included CN372394
6 comparison axes
Onset
11q Partial Monosomy Syndrome C0795841
0-0
17 20 Lyase Deficiency Isolated Included CN372394
0-16
Onset patterns differ
Severity
11q Partial Monosomy Syndrome C0795841
severe
17 20 Lyase Deficiency Isolated Included CN372394
severe
Different severity levels
Chronic
11q Partial Monosomy Syndrome C0795841
Chronic
17 20 Lyase Deficiency Isolated Included CN372394
Chronic
Differing course
Communicable
11q Partial Monosomy Syndrome C0795841
No
17 20 Lyase Deficiency Isolated Included CN372394
No
Different transmission
Body System
11q Partial Monosomy Syndrome C0795841
congenital
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
Same/different system
Category
11q Partial Monosomy Syndrome C0795841
genetic
17 20 Lyase Deficiency Isolated Included CN372394
endocrine
Different category
Bottom line
11q-partial-monosomy-syndrome-C0795841 and 17-20-lyase-deficiency-isolated-included-CN372394 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 11q Partial Monosomy Syndrome C0795841 | 17 20 Lyase Deficiency Isolated Included CN372394 | Discriminating power |
|---|---|---|---|
| Development | Developmental delay or intellectual disability is typical. | Cognition is not the defining feature from available data. | High |
| Physical pattern | Facial differences and other congenital anomalies may occur. | Genital atypicality or absent puberty may be the main clue. | High |
| Hormone-related features | Not primarily a sex-steroid synthesis disorder. | Undervirilization or pubertal failure suggests impaired sex-steroid production. | Moderate |
When to favor each condition
Choose 11q Partial Monosomy Syndrome C0795841 when
Congenital anomalies with developmental delay
This pattern fits a chromosomal disorder better than isolated lyase deficiency.
High
Unexplained thrombocytopenia or bleeding tendency
Platelet abnormalities are associated with some 11q deletions, not this endocrine defect.
Moderate
Suspected chromosomal diagnosis
Genome-wide chromosomal testing is the appropriate first confirmation.
High
Choose 17 20 Lyase Deficiency Isolated Included CN372394 when
46,XY undervirilization or absent puberty
Disordered sex-steroid synthesis should be evaluated by an endocrinologist.
High
Steroid pattern suggesting selective lyase impairment
Preserved cortisol with low sex steroids may support this rare diagnosis, but cutoffs are not established here.
Moderate
Need to distinguish from broader adrenal enzyme defects
Isolated lyase deficiency is not the same as combined 17-hydroxylase/lyase deficiency.
Moderate
How key tests differ
| Test | 11q Partial Monosomy Syndrome C0795841 | 17 20 Lyase Deficiency Isolated Included CN372394 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May show partial loss of chromosome 11q material. | Not expected to diagnose this enzyme disorder. | A chromosomal result supports the left condition only when clinically correlated. |
| Steroid profile and sex hormones | No characteristic sex-steroid pattern is established. | Low sex steroids with a selective precursor pattern may be found. | Abnormal hormones are findings, not a definitive diagnosis without specialist review. |
| Targeted genetic testing | Chromosomal studies are more relevant than CYP17A1 or CYB5A testing. | CYP17A1, CYB5A, or related testing may be considered. | Gene choice depends on the steroid pattern and should be clinician-directed. |
Prognosis comparison
11q Partial Monosomy Syndrome C0795841
- Outcome
- Often a lifelong developmental condition; exact survival or disability cannot be stated from these data.
- Factors
- Extent of deleted material, congenital anomalies, and available supports may influence needs.
17 20 Lyase Deficiency Isolated Included CN372394
- Outcome
- Generally a chronic endocrine condition; long-term outcome data are too limited here for a firm prediction.
- Factors
- Degree of sex-steroid deficiency, age at recognition, and associated adrenal findings matter.
Time frame: Both may require lifelong follow-up, beginning in infancy or by adolescence.
Prognosis should be based on the individual’s confirmed diagnosis and complications, not this comparison alone.
Complications comparison
| Complication | Presentation |
|---|---|
| Congenital organ differences | Heart or other structural anomalies may occur. Structural anomalies outside sex development are not the core feature. Surveillance should follow identified anomalies rather than a fixed protocol from these data. |
| Hematologic problems | Low platelets and bleeding can occur in some patients. Bleeding is not an expected defining complication. Any bleeding needs clinical assessment; severity cannot be predicted here. |
| Reproductive development | Fertility effects are not specifically established by the supplied data. Impaired sex-steroid production may affect puberty and fertility. Counseling should be individualized and avoid unsupported outcome estimates. |
Patient education highlights
- HighDifferent causes
One is a chromosomal condition; the other is a rare hormone-synthesis disorder. They are not interchangeable diagnoses.
- HighSpecialist care
Genetics, developmental services, endocrinology, or hematology may be needed according to confirmed findings.
- MediumTest interpretation
An abnormal chromosome or hormone result requires clinician interpretation and may need confirmatory testing.